CPT codes and LOINC update: July 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of July.
CPT codes and LOINC update: September 2022 - Insights
This list includes updates posted to mayocliniclabs.com during the month of September.
Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic Leukemia - Insights
Curtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.
Patient Story Features the Importance of Neuroimmunology - Insights
Sean Pittock, M.D., and Andrew McKeon, M.B., B.Ch., M.D., were featured in a Post Bulletin series about autoimmune neurology disorders and the research and services that Mayo Clinic offers patients.
2017 Mayo Medical Laboratories Lab Week Door Winner - Insights
We wrapped up another fun National Medical Laboratory Professional’s Week with a door-decorating contest, weekly quizzes, and, of course, treats. This year’s theme was, “All-Stars Laboratory Team: Teaming up for Patient Care.” We ended up...
New Blood Test to Help Determine Heart Disease Highlighted in European Heart Journal - Insights
European Heart Journal recently highlighted Mayo Clinic's new blood test that may predict cardiovascular events in patients with or without coronary artery disease.
Mayo Clinic Pathology System Upgrade Resource Page - Insights
To ensure we continue to provide the highest level of value-based reference laboratory services, Mayo Medical Laboratories will be implementing a new pathology laboratory information system on Friday, Sept. 8, 2017. View the list of...
New Tests Launched in March - Insights
In March 2018, Mayo Medical Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Find out how our sarcoma panel assesses gene mutations and fusions described in more than 50 types of soft tissue, bone, and other mesenchymal tumors.
Browse our suite of fluorescence in situ hybridization tests designed to identify malignancies in select genes associated with eosinophilia.